TPST: Tempest Therapeutics Inc

TPST新闻

• 08:32 New Strong Buy Stocks for April 10th
• 21:57 Tempest Therapeutics完成CAR-T资产收购
• 16:36 Tempest Therapeutics股价在H.C. Wainwright上调评级后大涨
• 16:34 Tempest Therapeutics stock surges after H.C. Wainwright upgrade
• 11:54 H.C. Wainwright将Tempest Therapeutics股票评级上调至"买入"，目标价11美元
• 11:53 H.C. Wainwright upgrades Tempest Therapeutics stock rating to Buy with $11 target
• 21:34 Tempest Therapeutics收到纳斯达克年度股东大会合规通知
• 21:34 Tempest Therapeutics receives Nasdaq notice for annual meeting compliance
• 21:10 Tempest Therapeutics完成425万美元的注册直接发行
• 21:09 Tempest Therapeutics closes $4.25 million registered direct offering
• 14:06 Tempest Therapeutics股价在425万美元直接融资后下跌
• 14:05 Tempest Therapeutics stock falls after $4.25 million direct offering
• 13:05 Tempest Therapeutics raises $4.25 million in registered direct offering
• 21:30 U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.10%
• 21:30 美国股市上涨；截至收盘道琼斯工业平均指数上涨0.10%
• 16:15 Tempest Therapeutics股价在全股票收购后暴跌
• 14:13 Tempest Therapeutics to acquire Factor Bioscience’s CAR-T programs
• 12:58 Crude Oil Falls Over 2%; Lowe's Shares Gain After Q3 Results - Agios Pharmaceuticals (NASDAQ:AGIO), Carver Bancorp (NASDAQ:CARV)
• 11:42 Nasdaq Gains Over 100 Points; Target Trims Earnings Forecast - Freight Technologies (NASDAQ:FRGT), Carver Bancorp (NASDAQ:CARV)
• 11:33 Why Tempest Therapeutics (TPST) Stock Is Down 45% Today - Tempest Therapeutics (NASDAQ:TPST)
• 11:00 Biodexa Moves Into Phase 3 With eRapa For FAP With First Patient Enrolled - Biodexa Pharmaceuticals (NASDAQ:BDRX), Pfizer (NYSE:PFE)
• 10:59 How Biodexa Is Racing To Get Its Phase 3 Program In FAP Under Way And Gain First-Mover Advantage In A $7B Addressable Market - Biodexa Pharmaceuticals (NASDAQ:BDRX), Palvella Therapeutics (NASDAQ:PVLA)
• 12:25 Tempest gets NMPA approval for pivotal trial of liver cancer drug
• 11:54 Tempest Therapeutics ends ATM prospectus with Jefferies